Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Melissa L. Cull"'
Autor:
Robert E.J. Ryder, Katharina Laubner, Marek Benes, Martin Haluzik, Lynne Munro, Harry Frydenberg, Julian P. Teare, Aruchuna Ruban, Sigal Fishman, Erwin Santo, Rainer Stengel, Charlotte De Jonge, Jan W. Greve, Ricardo V. Cohen, Cristina M. Aboud, Gerald J. Holtmann, Graeme Rich, Jess J. McMaster, Tadej Battelino, Primoz Kotnik, James P. Byrne, John C. Mason, Justin Bessell, Jeanine Bascomb, Lillian Kow, Janes Collins, Jacob Chisholm, Peter N. Pferschy, Harald Sourij, Melissa L. Cull, Melanie C. Wyres, Russell Drummond, Barbara McGowan, Stephanie A. Amiel, Mahi Yadagiri, Piya Sen Gupta, Jens Aberle, Jochen Seufert
Publikováno v:
Diabetes Care. 46:e89-e91
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dab10af8e13494185d21848d0f3e18f3
https://doi.org/10.2337/dc22-1952
https://doi.org/10.2337/dc22-1952
Autor:
THOMAS S.J. CRABTREE, ALISON GALLAGHER, SIVA SIVAPPRIYAN, KETAN DHATARIYA, RAJEEV P. RAGHAVAN, ALEX BICKERTON, JACKIE ELLIOTT, MELISSA L. CULL, GERRY RAYMAN, IAN W. GALLEN, ISKANDAR R. IDRIS, ROBERT E. RYDER
Publikováno v:
Diabetes. 71
SGLT2i treatment is associated with weight and Hba1c reduction. Previous work has demonstrated clinical predictors of HbA1c and weight reduction with canagliflozin. We aim to analyse predictors of HbA1c and weight change across the class. Methods: Pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce65f288ecd0d9a8fab72ccc5100d889
https://doi.org/10.2337/db22-858-p
https://doi.org/10.2337/db22-858-p
Autor:
ROBERT E.J. RYDER, JULIAN P. TEARE, ARUCHUNA RUBAN, MARTIN HALUZIK, LYNNE MUNRO, HARRY FRYDENBERG, JESSICA J. MCMASTER, SIGAL FISHMAN, RAINER STENGEL, RICARDO V. COHEN, CRISTINA M. ABOUD, JAMES P. BYRNE, GERALD J. HOLTMANN, CHARLOTTE DE JONGE, JAN WILLEM GREVE, JOHN C. MASON, JUSTIN BESSELL, LILIAN KOW, HARALD SOURIJ, PETER N. PFERSCHY, MELISSA L. CULL, MELANIE C. WYRES, RUSSELL DRUMMOND, BARBARA MCGOWAN, STEPHANIE A. AMIEL, MAHENDER YADAGIRI, PIYA SEN GUPTA, KATHARINA LAUBNER, JOCHEN SEUFERT
Publikováno v:
Diabetes. 71
Uncertainty exists re risk:benefit of proximal intestinal exclusion with EB, a novel endoscopic duodenal jejunal liner device for obesity, both with and without diabetes. In view of this, during 2017, an independent, secure, on line registry was esta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5abec677b0d7dcff610c03942419351
https://doi.org/10.2337/db22-1415-p
https://doi.org/10.2337/db22-1415-p
Autor:
THOMAS S.J. CRABTREE, DEVESH K. SENNIK, ALEX BICKERTON, DENNIS BARNES, SIVA SIVAPPRIYAN, KAREN ADAMSON, SUZANNE M. PHILLIPS, ALISON EVANS, NIELS LARSEN, AVINASH PANESAR, MELISSA L. CULL, IAN W. GALLEN, ISKANDAR R. IDRIS, ROBERT E. RYDER
Publikováno v:
Diabetes. 71
Obesity and type 2 diabetes are important drivers for the development of nonalcoholic fatty liver disease (NAFLD) . Glucagon-like peptide-1 receptor agonists (GLP1RAs) are efficacious for these conditions, but their potential as treatments for NAFLD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e2a53c1a64d9740e2c4b01e07e65450
https://doi.org/10.2337/db22-756-p
https://doi.org/10.2337/db22-756-p
Autor:
Susan P. Irwin, Melanie C. Wyres, Rachael A Allden, Tahira Bashir, Wyn Burbridge, Mahi Yadagiri, Robert E.J. Ryder, Piya Sen Gupta, Mark R Anderson, John Bleasdale, Edward Fogden, Hardeep Gandhi, Melissa L. Cull
Publikováno v:
British Journal of Diabetes. 21:76-83
Aims: EndoBarrier is a 60 cm duodenal–jejunal bypass liner endoscopically implanted for up to one year. It mimics the bypass part of Roux-en-Y bariatric surgery and reduces weight and HbA1c while it is in situ. We aimed to assess the extent to whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9f2c714da621715f51b8062d88a02c7
https://doi.org/10.15277/bjd.2021.295
https://doi.org/10.15277/bjd.2021.295
Autor:
Mahi Yadagiri, Melissa L. Cull, Wyn Burbridge, Melanie C. Wyres, Hardeep Gandhi, Susan P. Irwin, John Bleasdale, Tahira Bashir, Piya Sen Gupta, Rachael A Allden, Mordel Wilson, Edward Fogden, Mark R Anderson, Robert E.J. Ryder
Publikováno v:
British Journal of Diabetes. 19:110-117
Aims: EndoBarrier is a 60 cm proximal intestinal liner, endoscopically implanted for up to 1 year, designed to mimic the bypass aspect of Roux-en-Y gastric bypass surgery. We aimed to assess its safety and efficacy in patients with advanced diabesity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3375ed50319a64840284efa6d4e3e76e
https://doi.org/10.15277/bjd.2019.226
https://doi.org/10.15277/bjd.2019.226
Autor:
Thomas Sj Crabtree, Devesh K. Sennik, Anurita Rohilla, Melissa L. Cull, Robert E.J. Ryder, Ian W. Gallen, Karen Adamson, Siva Sivappriyan, Alex Bickerton, Dennis Barnes
Publikováno v:
Diabetes. 70
In January 2019, the ABCD nationwide semaglutide audit was launched with the aim of providing real world evidence on semaglutide use in UK clinical practice. Methods: Data were extracted from the ABCD audit tools and included providing they had suffi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d71af88af169a4f03818ddeb50659db9
https://doi.org/10.2337/db21-686-p
https://doi.org/10.2337/db21-686-p
Autor:
Alison Evans, Mahender Yadagiri, Suzanne M. Phillips, Alex Bickerton, David M. Williams, Jeffrey W. Stephens, Marc Atkin, David S. Morris, Karen Adamson, Devesh K. Sennik, Ian W. Gallen, Melissa L. Cull, Robert E. Ryder, Thomas S.J. Crabtree, Rajeev Raghavan, Anthony M. Robinson, Anurita Rohilla
Publikováno v:
Diabetes. 69
Background: Sodium-glucose linked transporter 2 inhibitors (SGLT2s) are currently favoured for their tolerability, cardiovascular benefit and renal protective effects. However, due to their mechanism of action, they are only licensed for use in those
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::667dd37427974eafbcce5f93c7252f62
https://doi.org/10.2337/db20-1104-p
https://doi.org/10.2337/db20-1104-p
Autor:
Melissa L. Cull, Robert E. Ryder, Thomas S.J. Crabtree, Anurita Rohilla, Alison Evans, Alex Bickerton, Devesh K. Sennik, Ian W. Gallen, Anna Strzelecka, Suzanne M. Phillips, Mahender Yadagiri, Peter Winocour, Ken H. Darzy, Rajeev Raghavan
Publikováno v:
Diabetes. 69
Background: Nonalcoholic fatty liver disease (NAFLD) is common amongst those with type 2 diabetes (T2DM). Alanine aminotransferase (ALT) is known to correlate with levels of liver inflammation and fibrosis. Recent data from our audit programme showed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::951ddecbaa94d2fc0da372ee21172af9
https://doi.org/10.2337/db20-1105-p
https://doi.org/10.2337/db20-1105-p
Autor:
Melissa L. Cull, Robert E. Ryder, Thomas S.J. Crabtree, Marc Atkin, Alex Bickerton, David M. Williams, Anurita Rohilla, Suzanne M. Phillips, Devesh K. Sennik, Anthony M. Robinson, Mahender Yadagiri, Jeffrey W. Stephens, Ian W. Gallen, Rajeev Raghavan, Karen Adamson, Alison Evans, David S. Morris
Publikováno v:
Diabetes. 69
Background: Data previously presented from our audit programme showed that sodium-glucose co-transporter 2 inhibitors (SGLT2s) remain equally effective at reducing HbA1c irrespective of duration of diabetes. This analysis was performed to establish i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::519f792c3a6128eb8682ace87fb1c505
https://doi.org/10.2337/db20-2224-pub
https://doi.org/10.2337/db20-2224-pub